We enrolled a total of 100 individuals in this study: patients with acute myocardial infarction (AMI, n聽=聽25), unstable angina pectoris (UAP, n聽=聽20), or stable angina pectoris (n聽=聽35) who underwent coronary angiography, and control subjects (n聽=聽20). Three monocyte subsets (CD14++CD16鈭?/sup>, CD14++CD16+, and CD14+CD16+) and the expression of PSGL-1 were measured by flow cytometry. In patients with AMI and UAP, FD-OCT was performed before percutaneous coronary intervention. Circulating peripheral CD14++CD16+ monocytes expressed PSGL-1 more frequently than CD14++CD16鈭?/sup> and CD14+CD16+ monocytes in patients with ACS. The expression of PSGL-1 on circulating peripheral CD14++CD16+ monocytes was significantly elevated in patients with AMI compared with the other 3 groups. Moreover, the expression levels of PSGL-1 on CD14++CD16+ monocytes were significantly higher in patients with plaque rupture or intracoronary thrombus assessed by FD-OCT. Up-regulation of PSGL-1 on CD14++CD16+ monocytes may be a crucial role in plaque rupture and thrombus formation.Results
Conclusion